Feedback / Questions
lirentelimab (AK002) - Allakos
Rydapt (midostaurin) - Novartis
Ayvakit (avapritinib) - Blueprint Medicines
http://www.ncbi.nlm.nih.gov/pubmed/38217824
Alessandro Toscano; Athina Van Gasse; Didier G Ebo; Michiel Beyens; Vito Sabato
Jan 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next